Uncategorized
Insmed shelves Brinsupri in skin disease after mid-stage flop
Insmed has given up on Brinsupri in the painful skin disorder hidradenitis suppurativa (HS) after a mid-stage trial failure. The company had ditched the pill in sinus inflammation at the end of last year.
The …